← Eichor
Study identifier: NCT07076966 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of Adenoma Detection Rate in 3D vs. 2D Surveillance Colonoscopy

Condition: Colonoscopy · Adenoma Detection Rate · Three Dimensional  ·  Sponsor: National Taiwan University Hospital

PhaseNA
Planned participants500
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersNo

About this study

There is substantial evidence confirming that identifying and removing colorectal adenomas during colonoscopy helps prevent the development of colorectal cancer. Among the quality indicators for colonoscopy, adenoma detection rate (ADR) is the most important, as it is closely related to the patient's future risk of colorectal cancer. Recent studies have further demonstrated that improving ADR can reduce future mortality from colorectal cancer. Notably, non-polypoid lesions (such as flat or depressed lesions) are more likely to be missed during traditional colonoscopy, making these lesions a leading cause of post-colonoscopy interval colorectal cancer. In a prospective trial conducted by our team comparing the ADR of 3D colonoscopy with standard 2D colonoscopy, we found that 3D colonoscopy significantly improved overall ADR and the detection rate of non-polypoid adenomas. According to current international guidelines, after an index colonoscopy, patients are recommended to undergo surveillance colonoscopy 1 to 10 years later, depending on their findings at index colonoscopy. Since these patients represent the majority in clinical practice, increasing the ADR during surveillance colonoscopy not only allows for more precise recommendations for the timing of the next colonoscopy but also effectively reduces the risk of post-colonoscopy colorectal cancer (PCCRC). Therefore, this multicenter, prospective, randomized trial aims to compare the clinical performance of 3D colonoscop…

This description comes directly from the study's public registry record.

Talk to the study team

Li-Chun Chang, MD. PhD.  ·  886-9-72-651-258  ·  lichunchang@ntu.edu.tw

Always discuss trial participation with your own doctor first.

Locations (3)

National Taiwan University Hospital, Hsinchu BranchHsinchu, Taiwan, TaiwanRecruiting
National Taiwan University Cancer CenterTaipei, Taiwan, TaiwanRecruiting
National Taiwan University HospitalTaipei, Taiwan, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07076966